Aurobindo Pharma arm recalls 59k vials of antipsychotic Fluphenazine Decanoate injection from US Medical Dialogues Bureau13 Dec 2019 9:30 AM ISTAurobindo Pharma arm AuroMedics Pharma LLC is recalling 59,500 vials of the injection on account of "Discoloration; hazy solution found in one vial...
Sarepta Therapeutics newest DMD treatment Vyondys 53 gets early USFDA nod Medical Dialogues Bureau13 Dec 2019 9:30 AM IST Sarepta Therapeutics said the new treatment Vyondys 53 is priced at parity to its first DMD drug, Exondys 51, which is priced at about $300,000 per...
Cipla associate Avenue Therapeutics files US application for IV tramadol Farhat Nasim12 Dec 2019 3:30 PM ISTNew Delhi: Cipla Ltd's associate company, Avenue Therapeutics, Inc. ("Avenue"), a company focused on the development of intravenous ("IV") tramadol...
Zydus Cadila unveils affordable anti-diabetic drug Vildagliptin under brands Vinglyn, Vinglyn M Medical Dialogues Bureau12 Dec 2019 11:53 AM ISTAhmedabad: With the Novartis Blockbuster Vildagliptin going off patent, Zydus Cadila has taken made its move towards affordable diabetes care in India...
Mumbai-based Eurolife Healthcare to infuse Rs 100 crore for expanding production Medical Dialogues Bureau12 Dec 2019 9:30 AM ISTAs a first step, the company has signed up a deal with a Chinese firm for procuring high-speed machines which would enable Eurolife manufactures the...
Sanofi, Regeneron to restructure antibody collaboration for Kevzara, Praluent Farhat Nasim12 Dec 2019 9:20 AM ISTUnder the proposed restructuring, Sanofi is expected to gain sole global rights to Kevzara and sole ex-U.S. rights to Praluent. Regeneron is expected...
AstraZeneca-Daiichi trastuzumab deruxtecan halts cancer for months in first readout Medical Dialogues Bureau12 Dec 2019 9:05 AM IST"This is a totally unprecedented clinical benefit," Jose Baselga, AstraZeneca's head of oncology research and development said of the so-called...
CDSCO approves over 3000 global clinical trial sites, investigators; prepares comprehensive database Farhat Nasim11 Dec 2019 2:41 PM ISTCDSCO is preparing a comprehensive database of sites and investigators involved in the conduct of the clinical trial in different therapeutic...
Subscription of Piramal debentures by Canadian investor approved by CCI Medical Dialogues Bureau11 Dec 2019 12:28 PM ISTThe Competition Commission of India (CCI) in a tweet said it "approves the subscription of CCDs of Piramal Enterprises by CDPQ. Upon conversion, the...
Merck to acquire cancer drug developer ArQule for USD 2.7 billion Farhat Nasim11 Dec 2019 9:30 AM ISTNew Delhi: Merck, known as MSD outside the United States and Canada, and ArQule, Inc. recently announced that the companies have entered into a...
Sanofi closes research in diabetes, cardiovascular diseases; narrows units to spur profit Medical Dialogues Bureau11 Dec 2019 9:15 AM ISTSanofi, which is due to further detail strategic plans to investors on Tuesday in Cambridge, Massachusetts, said it was targeting new cost savings of...
SETBACK: Correvio Pharma heart drug Brinavess fails to win USFDA panel backing Medical Dialogues Bureau11 Dec 2019 9:10 AM ISTThe panel voted 11-2 against approving Correvio Pharma's drug, Brinavess, citing serious safety risks, including low blood pressure and irregular...
